20 May 2015
Over the past ten years, the field of researchers dedicated to bladder cancer has flourished. Until recently, there has not been a journal solely focused on advances relevant to bladder cancer, across the continuum of research. Recognizing this unmet need, Seth Lerner and Dan Theodorescu convened a first-class Editorial Board and partnered with IOS Press to create Bladder Cancer, an international journal devoted solely to the study of bladder cancer (ISSN: 2352-3727). The journal will provide an open forum for original research geared towards improving our understanding of bladder cancer, from the lab bench to the clinic, and to the population at large. The journal will cover all aspects of bladder cancer research, including basic science, translational research, clinical studies, ethics, patient advocacy, and survivorship issues. Researchers, patients, and others are encouraged to submit research reports as well as short communications and letters-to-the editor.
Our hope is that Bladder Cancer will become an avenue for multidisciplinary dialogue and a forum to provide greater public awareness of this important disease. The launch of this publication is an important milestone and sends a message to the community. Bladder cancer is an important research topic and we can work together to identify new treatments and improve the quality of life for patients.
The journal is now accepting papers and offers rigorous peer review and rapid online publication (pre-print) on acceptance.
The Bladder Cancer publication may be found online at http://content.iospress.com/journals/bladder-cancer/1/1 with free downloads available. The journal also hosts Twitter and Facebook news feeds.
Post submitted by Angela B. Smith, M.D., M.S. and Matthew Nielsen, M.D., M.S. of the University of North Carolina, Social Media Editors for Bladder Cancer.
